JOSEPH R. GOODWIN, District Judge.
Pending are (1) Defendant's Motion to Dismiss, filed by Tissue Science Laboratories Limited ("TSL") on March 30, 2018 [ECF No. 17]; and (2) Defendant C.R. Bard, Inc.'s Notice of Joinder in Defendant Tissue Science Laboratories Ltd.'s Motion to Dismiss, filed July 17, 2019 [ECF No. 23]. Defendant TSL asserts in the first Motion [ECF No. 17], joined by C. R. Bard, Inc. ("Bard") [ECF No. 23], that plaintiffs' case should be dismissed with prejudice for failure to comply with court orders, including the failure to timely provide the defendants with required pretrial discovery in violation of Pretrial Order Numbers 27, 28 and 275. Plaintiffs, who are pro se, have not responded. It appears from the docket that the plaintiffs' address is not current.
On July 10, 2019, the court entered a Show Cause Order directing plaintiffs to show cause on or before July 24, 2019, why the defendant who filed the first motion should not be dismissed. [ECF No. 22]. The court sent a copy of this order to plaintiffs at their last known address and posted it on the court's public website. Plaintiffs did not show cause or otherwise respond.
The court finds, pursuant to Rules 16 and 37 of the Federal Rules of Civil Procedure and after weighing the factors identified in Wilson v. Volkswagen of Am., Inc., 561 F.2d 494, 503-06 (4th Cir. 1977), that this case should be dismissed without prejudice for plaintiffs' failure to respond to the show cause order and otherwise comply with discovery deadlines in compliance with the court's previous pretrial and other orders.
Therefore, the court
The court